SG Americas Securities’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,753
Closed -$147K 2915
2025
Q1
$147K Buy
9,753
+3,557
+57% +$59.2K ﹤0.01% 2756
2024
Q4
$102K Sell
6,196
-3,289
-35% -$64.9K ﹤0.01% 2723
2024
Q3
$234K Buy
9,485
+2,858
+43% +$74.1K ﹤0.01% 2363
2024
Q2
$168K Sell
6,627
-1,988
-23% -$51.5K ﹤0.01% 2262
2024
Q1
$219K Buy
8,615
+627
+8% +$15.2K ﹤0.01% 1909
2023
Q4
$181K Buy
7,988
+1,341
+20% +$27.7K ﹤0.01% 2256
2023
Q3
$124K Buy
+6,647
New +$138K ﹤0.01% 2649
2023
Q2
Sell
-7,358
Closed -$211K 2269
2023
Q1
$211K Buy
+7,358
New +$219K ﹤0.01% 2378
2022
Q1
Sell
-16,439
Closed -$589K 2941
2021
Q4
$589K Sell
16,439
-851
-5% -$34.1K ﹤0.01% 2054
2021
Q3
$736K Buy
+17,290
New +$712K ﹤0.01% 2175
2021
Q2
Sell
-16,334
Closed -$666K 2839
2021
Q1
$666K Buy
+16,334
New +$620K ﹤0.01% 1806
2020
Q4
Sell
-41,849
Closed -$1.48M 3320
2020
Q3
$1.48M Buy
41,849
+32,811
+363% +$1.19M 0.01% 949
2020
Q2
$341K Buy
9,038
+3,499
+63% +$115K ﹤0.01% 2423
2020
Q1
$160K Buy
5,539
+1,169
+27% +$47.3K ﹤0.01% 2669
2019
Q4
$227K Sell
4,370
-42,806
-91% -$2.49M ﹤0.01% 2390
2019
Q3
$2.59M Buy
47,176
+41,421
+720% +$2.13M 0.02% 787
2019
Q2
$234K Sell
5,755
-722
-11% -$26.3K ﹤0.01% 2328
2019
Q1
$196K Buy
6,477
+3,235
+100% +$111K ﹤0.01% 2587
2018
Q4
$109K Sell
3,242
-596
-16% -$21.5K ﹤0.01% 2687
2018
Q3
$162K Sell
3,838
-2,690
-41% -$106K ﹤0.01% 2661
2018
Q2
$209K Buy
+6,528
New +$269K ﹤0.01% 2577
2017
Q4
Sell
-2,041
Closed -$118K 3170
2017
Q3
$118K Buy
+2,041
New +$107K ﹤0.01% 3066
2017
Q1
Sell
-3,163
Closed -$155K 3260
2016
Q4
$155K Sell
3,163
-770
-20% -$35.6K ﹤0.01% 2547
2016
Q3
$188K Buy
+3,933
New +$194K ﹤0.01% 2545
2015
Q1
Sell
-4,044
Closed -$165K 2501
2014
Q4
$165K Buy
+4,044
New +$158K ﹤0.01% 2574

Other funds holding ANIK